IBA Dosimetry Clinical Presentations Header
Best Practices and Experience with Dosimetry & QA Solutions

Clinical Presentations Hub

Easily access the clinical presentations hub to watch the content you like at any time.

Login or Register here

test

Stereotactic clinical experience with myQA SRS on pre-treatment verification of multi-target brain plans

Guest speaker Dr. Guoqiang Cui, a medical physicist from Duke University Medical Center, shares his stereotactic clinical experience with myQA SRS in the USA.

Dr. Guoqiang Cui

Assistant Professor of Radiation Oncology
Duke University Medical Center

5 min. (open access preview)46 min. (full presentation, members)

A new high-resolution digital SRS and SBRT QA detector array: Performance characterisation and clinical advantages

Learn about the physics characteristics of myQA SRS as evaluated by clinical users. Guest speakers Dr. Sally Fletcher and Dr. Chris Stepanek from University Hospitals Bristol & Weston (UHBW) NHS Foundation Trust, UK, present their findings from extensive testing of the myQA SRS.

Sally Fletcher & Chris Stepanek

Sally Fletcher, Head of Radiotherapy Physics Department, Bristol Haematology and Oncology Centre


Chris Stepanek, Trainee Clinical Scientist in Radiotherapy Physics, University Hospitals Bristol & Weston

3 min. (open access preview)17 min. (full presentation, members)

Novel stereotactic QA with film-class resolution: First clinical experience with myQA SRS

Learn about the physics characteristics and clinical performance of the new myQA SRS solution. Guest speaker Yun Yang, PhD, DABR, Medical Physicist at Rhode Island Hospital, USA, presents his findings from extensive testing of the myQA SRS at Rhode Island Hospital.

CME: This presentation was approved by CAMPEP for 1 MPCEC hour and accredited by EBAMP as CPD event for Medical Physicists at EQF Level 7 and awarded 9 CPD credit points (only applicable for the live webinar - watch out for our next CME webinars).

 

Yun Yang, PhD, DABR,

Medical Physicist at Rhode Island Hospital, USA.

3 min. (open access preview)34 min. (full presentation, members)

SBRT part 3: Quality assurance for SBRT treatments

Learn about current strategies and future developments in the field of Quality assurance for SBRT treatments.

Dr. Kai SchubertMedical Physicist at Clinic for Radiation Oncology and Radiation Therapy
University Clinic of Heidelberg, Germany
2 min (open access preview)19 min. (full presentation, members)

SBRT part 2: The role of SBRT in the treatment of oligometastatic prostate cancer: Why & how SBRT for these patients

Learn how the oligometastatic status of prostate cancer patients is defined on the basis of PSMA PET/CT and which strategies and modalities are applied for SBRT treatment of these patients.

PD Dr. med. Stefan KörberFirst Senior Medical Doctor at Clinic for Radiation Oncology and Radiation Therapy
University Clinic of Heidelberg, Germany
3 min. (open access preview)16 min. (full presentation, members)

SBRT part 1: Impact of PSMA PET on the management of patients with oligo metastatic prostate cancer

Learn about the concept of oligometastatic disease on prostate cancer patients and the importance of highly sensitive and specific PET PSMA imaging in the therapy management of those patients.

Jeremie Calais MD MScDirector of the Clinical Research Program of the Nuclear Medicine and
Theranostics Division, UCLA
3 min. (open access preview)20 min. (full presentation, members)

Small Field Dosimetry – Tips & Tricks

Comprehensive presentation about challenges and considerations for clinical small photon field dosimetry based on international standards (IAEA, AAPM etc). Learn about tips and tricks to achieve high-quality results.

Eduard Gershkevitsh, Chief Medical PhysicistNorth Estonia Medical Centre, Tallinn, Estonia
3 min. (open access preview)30 min. (full presentation, members)

1) All product and company names are trademarks or registered trademarks of their respective holders. Use of them does not imply any relationship, sponsorship, or endorsement between IBA or its products and the owners of these trademarks.